Virus

Commonly used antibiotic shows promise for combating Zika infections

2 monthes ago   |   By ScienceDaily

Researchers used a variety of advanced drug screening techniques to test out more than 10,000 compounds in search of a cure. To their surprise, they found that the widely used antibiotic methacycline was effective at preventing brain infections and reducing neurological problems associated with the virus in mice.
Read more ...

 


Search by Tags

   Virus      Research      Antibiotics      Brain      Neurology      Drugs      Drug  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bond LSC Researchers Named Most Highly Cited for 2020

Bond LSC Researchers Named Most Highly Cited for 2020

Bond Life Sciences Center principal investigators Bing Yang and Ron Mittler are pictured above. | photos by Erica Overfelt, Bond LSC. By Lauren Hines | Bond LSC Building onto... Read more ...

A New Way to Measure Record-Setting Electron Beams

A New Way to Measure Record-Setting Electron Beams

Sam Barber, left, a research scientist at Berkeley Lab's BELLA Center, and Jeroen van Tilborg, a staff scientist at the BELLA Center, hold the active plasma lens, right, and... Read more ...

Researchers Find Cerebrospinal Fluid Boosts Cancer Cell Aggression

Researchers Find Cerebrospinal Fluid Boosts Cancer Cell Aggression

In cell studies, Mayo researchers and collaborators have uncovered why tumor cells from glioblastoma are more aggressive in one part of the brain than in others. In an article... Read more ...

Historical evolution of spheroids and organoids, and possibilities of use in...

Historical evolution of spheroids and organoids, and possibilities of use in life sciences and medicine

Abstract Background An impressive percentage of biomedical advances were achieved through animal research and cell culture investigations. For drug testing and disease... Read more ...

PSC Software™ Announces the Release of Microsoft Office 365 Integration in...

PSC Software™ Announces the Release of Microsoft Office 365 Integration in Adaptive Compliance Engine® Version 3.5.0

Written By: PSC Software Business Development and Marketing Teams PSC Software , a wholly owned subsidiary of PSC Biotech Corporation , is pleased to announce the integration... Read more ...

The Importance of Good Documentation Practices

The Importance of Good Documentation Practices

Written By: Akshaya Mohan, Regulatory Affairs Manager, PSC Biotech® Documentation is a “record” or “evidence” of an event that has happened. In the life-science industry “If it... Read more ...

Genome-editing tool TALEN outperforms CRISPR-Cas9 in tightly packed DNA

Researchers used single-molecule imaging to compare the genome-editing tools CRISPR-Cas9 and TALEN. Their experiments revealed that TALEN is up to five times more efficient... Read more ...

Blocking drug efflux mechanisms facilitate genome engineering process in...

Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable... Read more ...

Approaches to genetic tool development for rapid domestication of non-model...

Non-model microorganisms often possess complex phenotypes that could be important for the future of biofuel and chemical production. They have received significant interest the... Read more ...

Design Therapeutics Secures $125 Million in Series B Financing to Advance...

SAN DIEGO--Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders... Read more ...